Abingdon Health (ABDX)

Sector:

Health Care

Index:

FTSE AIM All-Share

4.75p
   
  • Change Today:
    -0.50p
  • 52 Week High: 14.00
  • 52 Week Low: 3.75
  • Currency: UK Pounds
  • Shares Issued: 121.72m
  • Volume: 192,410
  • Market Cap: £5.78m

Abingdon Health confident moving into 2023

By Josh White

Date: Monday 19 Dec 2022

LONDON (ShareCast) - (Sharecast News) - Diagnostic test developer and manufacturer Abingdon Health said in an update on Monday that its outlook moving into 2023 remained unchanged.
The AIM-traded firm, which was holding its annual general meeting, said recently in its preliminary results that its strategic focus was now on contract development and manufacturing (CDMO) services.

Chief executive officer Chris Yates told shareholders on Monday that it was focussing on such services, given the expected growth in demand it expected to see within the lateral flow market, particularly in non-Covid-19 sectors such as human health, animal health, plant pathogen and environmental testing.

"Our outlook going into 2023 is unchanged, and we remain confident that our contract services customer base and current growing pipeline mean we are well positioned to grow our business," Yates said.

"We are also reassured by our cash levels of £4.4m as at 19 December, in line with the cash position as at the end of October, and expect to have about £4.3m cash at the end of December.

"The board remains confident that we have sufficient cash resources to fund progress beyond the next 12 months, with our priority being to move the company to a positive cash flow position."

At 1225 GMT, shares in Abingdon Health were up 10.67% at 4.15p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ABDX Market Data

Currency UK Pounds
Share Price 4.75p
Change Today -0.50p
% Change -9.52 %
52 Week High 14.00
52 Week Low 3.75
Volume 192,410
Shares Issued 121.72m
Market Cap £5.78m

ABDX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.95% above the market average23.95% above the market average23.95% above the market average23.95% above the market average23.95% above the market average
8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average
Price Trend
90.6% below the market average90.6% below the market average90.6% below the market average90.6% below the market average90.6% below the market average
89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average
Income Not Available
Growth
19.47% below the market average19.47% below the market average19.47% below the market average19.47% below the market average19.47% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

ABDX Dividends

No dividends found

Trades for 24-Mar-2023

Time Volume / Share Price
16:29 100,364 @ 4.97p
15:14 2,000 @ 4.68p
15:00 1,001 @ 4.68p
14:08 20,000 @ 4.97p
12:04 10,000 @ 4.97p

ABDX Key Personnel

CEO Chris Henry Francis Yates
CFO Melanie Ross

Top of Page